Concepedia

Yin‐Ling Xiu

YX

Statistics

Publications

15

Citations

750

H-Index

15

Active since

2013

Affiliations

First Hospital of China Medical University(Current)

China Medical University

Kanagawa Prefectural Hospital Organization

Kanagawa Cancer Center

Yin‐Ling Xiu is an author at First Hospital of China Medical University specializing in medicine, oncology, and ovarian cancer.

Publications per year

2013–2022

15

Publications

15

Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3

Yin‐Ling Xiu, Kaixuan Sun, Xi Chen et al. · Oncotarget · 2017 · 104 citations · Full text

, , +17

MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression

Shuo Chen, Xi Chen, Yin‐Ling Xiu et al. · Cancer Letters · 2015 · 94 citations

, , +14

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression

Jing Yan, Jingyi Jiang, Xiaona Meng et al. · Journal of Experimental & Clinical Cancer Research · 2016 · 78 citations · Full text

, , +17

<scp>DLEU</scp>1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR‐490‐3p and altering <scp>CDK</scp>1 expression

Lili Wang, Kaixuan Sun, Dandan Wu et al. · Journal of Cellular and Molecular Medicine · 2017 · 72 citations · Full text

, , +17

RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression

Xi Chen, Shuo Chen, Yin‐Ling Xiu et al. · Molecular Cancer · 2015 · 71 citations · Full text

, , +17

1–5 of 15